HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HOMATROPINE METHYLBROMIDE; HYDROCODONE B) — FDA Approval ANDA204765 (SCIEGEN
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HOMATROPINE METHYLBROMIDE; HYDROCODONE B) — FDA Approval ANDA204765 (SCIEGEN is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE; Active ingredients: HOMATROPINE METHYLBROMIDE; H
| Brand name | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE |
|---|---|
| Active ingredients | HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE |
| Application number | ANDA204765 |
| Sponsor | SCIEGEN PHARMS |
| Dosage form | SYRUP |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20170306 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →